第21章-抗心绞痛与抗动脉粥样硬化药课件.ppt
《第21章-抗心绞痛与抗动脉粥样硬化药课件.ppt》由会员分享,可在线阅读,更多相关《第21章-抗心绞痛与抗动脉粥样硬化药课件.ppt(31页珍藏版)》请在淘文阁 - 分享文档赚钱的网站上搜索。
1、 Antianginal Drugs Zhu Yi Zhun,Dept.of Pharmacology,SPFDUEmail:HypertensionTherefore,it is important to treat hypertension and reduce mortality and morbidity of these conditions End organ damageis associated with increased risk from ischemic heart disease,cerebrovascular accidents,heart and renal fa
2、ilure.Complications of untreated hypertensionHypertensive cardiovascular diseaseHypertensive cerebrovascular disease and dementiaHypertensive renal diseaseAortic dissectionAtherosclerotic complicationLEADING CAUSES OF MORTALITY IN WHO REPORTLEADING CAUSES OF MORTALITY IN WHO REPORTThe mortality of i
3、schaemic heart disease is ranked first among other diseases in the WHO statisticsMYOCARDIAL INFARCTIONMYOCARDIAL INFARCTIONMyocardial Infarction generally occurs with the abrupt decrease in coronary blood flow that follows a thrombotic occlusion of a coronary artery leads to irreversible myocardial
4、cells damage and necrosis.Angina pectorisIs the most common condition involving in tissue ischemiaVasodilator drugs are commonly used(e.g.nitroglycerin,calcium channel blocker)-blockers are also useful VasodilatorsCalcium channels blockers:arteriodilator(e.g.Nifedipine硝苯地平,verapamil异搏定,diltiazem硫氮卓酮
5、)Nitrites(increase NO):venodilator(+),Arterioles(+),ischemic zone(+).ACE inhibitors(e.g.Captopril开普通)and angiotensin II receptor antagonists(Losartan氯沙坦):mixed Nitrates&Nitrites(硝酸盐硝酸盐&亚硝酸盐亚硝酸盐)Mechanisms of action in Angina:*Endothelial-derived relaxation factor(EDRF内皮内皮衍生的松弛因子衍生的松弛因子)nitric oxide(
6、NO):induces coronary vasodilation*Nitrates dilate coronary arteries to:1)redistribute blood flow from epicardial to endocardial regions.2)relieve coronary spasm and dynamic stenosis*Reduce oxygen demandNitrates/Nitrites NO Relaxation Drugs used to treat AnginaNitrites:Amyl Nitrite(戊基亚硝酸盐戊基亚硝酸盐)Side-
7、effects of NitratesHeadache-most common side-effectwith long-acting preparations:the development of tolerance,worsening of the underlying diseases process.Failure of nitrate therapywith short-acting preparations:noncompliance(headache),loss of potency of the tablets,and incorrect timingHypotension-m
- 配套讲稿:
如PPT文件的首页显示word图标,表示该PPT已包含配套word讲稿。双击word图标可打开word文档。
- 特殊限制:
部分文档作品中含有的国旗、国徽等图片,仅作为作品整体效果示例展示,禁止商用。设计者仅对作品中独创性部分享有著作权。
- 关 键 词:
- 21 心绞痛 动脉粥样硬化 课件
限制150内